期刊文献+

高产舍雷肽酶的粘质沙雷氏菌诱变选育 被引量:3

Mutation breeding of Serratia marcescens strains for serrapeptase high-yield production
下载PDF
导出
摘要 舍雷肽酶是一种来自粘质沙雷氏菌(Serratia marcescens)的碱性蛋白酶,具有良好的抗炎和抗肿胀作用,应用于临床疾病的治疗已有多年。为了获得产酶活力高、传代稳定且不产灵菌红素的舍雷肽酶发酵生产菌株,以1株分离自家蚕(Bombyx mori)肠道,产舍雷肽酶的粘质沙雷氏菌LL-413为出发菌株,用紫外线和微波连续诱变,经过筛选,获得了2株产酶能力高,不产灵菌红素,且传代稳定的突变株MW-9和MW-14菌株,产酶活力分别达到982 U/mL和956 U/mL,是原始菌株的1.98倍和1.92倍。 Serrapeptase is a kind of alkaline protease from Serratia marcescens.Due to its excellent anti-inflammatory and anti-swelling function,serrapeptase has been applied to treat some diseases in clinical for many years.In order to obtain strains with the characteristics of fine hereditary stability and prodigiosin negative for high-yield production of serrapeptase,a strain isolated from the intestine of silkworm(Bombyx mori),S.marcescens LL-413 was mutated by ultraviolet and microwave continuously.As results,2 strains,designated as MW-9 and MW-14,were selected out.Their productivity of serrapeptase was 982 U/mL and 956 U/mL,which respectively was 1.98 and 1.92 times higher than that of the original strain.
作者 梅建凤 蔡少芬 李靓 易喻 应国清 MEI Jian-feng;CAI Shao-fen;LI Liang;Yi Yu;YING Guo-qing(College of Pharmaceutical Science,Zhejiang University of Technology,Hangzhou 310014,China;Zhejiang Tianke High Technology Development Co.Ltd.,Hangzhou 310012,China)
出处 《食品与发酵工业》 CAS CSCD 北大核心 2018年第8期177-180,共4页 Food and Fermentation Industries
关键词 舍雷肽酶 粘质沙雷氏菌 诱变育种 紫外线 微波 serrapeptase Serratia marcescens mutation ultraviolet microwave
  • 相关文献

参考文献5

二级参考文献39

  • 1陈晓琳,唐欣昀,周隆义.枯草杆菌SOD高产菌株的诱变选育及产酶条件研究[J].激光生物学报,2005,14(3):173-176. 被引量:9
  • 2李朋,周小庆.达先片治疗急性附睾炎疗效观察[J].现代中西医结合杂志,2006,15(16):2220-2220. 被引量:2
  • 3殷凯生,付完珍,何礼贤,李善群,施毅,肖永营,于浩,韩振杰.舍雷肽酶肠溶片黏痰溶解与祛痰疗效的多中心随机双盲对照临床研究[J].中国新药与临床杂志,2006,25(10):737-740. 被引量:9
  • 4汪杏莉,李宗伟,陈林海,刘晓波,谢慧波.工业微生物物理诱变育种技术的新进展[J].生物技术通报,2007,23(2):114-118. 被引量:30
  • 5MAJIMA Y, INAGAKI M, HIRATA K, et al. The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus [J]. Arch Otorhinolayngol, 1988, 244 (6) : 335-359.
  • 6ESCH PM, GERNGROSS H, FABIAN A. Reduction of postoperative swelling. Objection measurement of swelling of the upper ankle joint in treatment with serrapeptase--a prospective study[J]. Fortschr Med, 1989, 107 (4): 67-68.
  • 7津山直一,古谷誠.足開節捻挫に伴う腄脹に對ずるグ一ゼン錠の臨床的檢討[J].醫學のぁゅみ,1985,123(9):892-903.
  • 8KEE WH, TAN SL, LEE V, et al. The treatment of breast engorgement with serrapeptase: a randomised double-blind controlled trial[J]. Singapore Med J, 1989, 30( 1 ) : 48-54.
  • 9MECIKOGLU M, SAYGI B, YILDIRIM Y, et al. The effect of proteolytie enzyme serratiopeptidase in the treatment of experimental implant-related infection[J]. J Bone Joint Surg Am, 2006, 88(6): 1208-1214.
  • 10SELAN L, BERLUTI F, PASSARIELLO C, et al. Proteolytic enzymes: a new treatment strategy for prosthetic infections?[J]. Antimicrob Agents Chemother, 1993, 37 (12) : 2618-2621.

共引文献40

同被引文献9

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部